S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Perceptive Advisors/Q4 2022

Perceptive Advisors

Periodo: Q4 2022 Β· Depositato: 2023-02-14
Vedi su SEC EDGAR β†—
AUM
$3.56B
Valore totale del portafoglio
Posizioni
96
Titoli dichiarati
Prima Posizione
FOLD
9.5% $337.5M
Var. Trimestrali
+8 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2023-02-14) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
FOLDAMICUS THERAPEUTICS INC$337.5M9.48%β€”β€”
9.5%
AMLXAMYLYX PHARMACEUTICALS INC$225.0M6.32%$35.98$18.27-49.2%
6.3%
MDGLMADRIGAL PHARMACEUTICALS INC$212.4M5.97%$285.42$528.10+85.0%
6.0%
CERECEREVEL THERAPEUTICS HLDNG I$205.4M5.77%β€”β€”
5.8%
RXDXPROMETHEUS BIOSCIENCES INC$133.4M3.75%β€”β€”
3.8%
VRNAVERONA PHARMA PLC$127.5M3.58%β€”β€”
3.6%
HZNPHORIZON THERAPEUTICS PUB L$109.3M3.07%β€”β€”
3.1%
MRTXMIRATI THERAPEUTICS INC$99.3M2.79%β€”β€”
2.8%
LIANYLIANBIO$94.4M2.65%$0.00$0.12
2.6%
MDGLPUTMADRIGAL PHARMACEUTICALS INC$87.1M2.45%$285.42$528.10+85.0%
2.5%
SRPTSAREPTA THERAPEUTICS INC$84.1M2.36%$124.84$19.28-84.6%
2.4%
INBXINHIBRX INC$81.7M2.29%β€”$97.58
2.3%
ACLXARCELLX INC$80.5M2.26%$31.03β€”
2.3%
ALDXALDEYRA THERAPEUTICS INC$79.0M2.22%$6.96$2.27-67.4%
2.2%
XENEXENON PHARMACEUTICALS INC$75.8M2.13%$37.26$60.96+63.6%
2.1%
CRNXCRINETICS PHARMACEUTICALS IN$73.9M2.08%$18.10$42.23+133.3%
2.1%
BLUBELLUS HEALTH INC NEW$73.1M2.05%β€”β€”
2.0%
SWTXSPRINGWORKS THERAPEUTICS INC$68.1M1.91%β€”β€”
1.9%
NUVLNUVALENT INC$67.2M1.89%$28.97$123.73+327.1%
1.9%
IOVAIOVANCE BIOTHERAPEUTICS INC$63.7M1.79%$6.11$4.31-29.5%
1.8%
PCVXVAXCYTE INC$56.1M1.58%$47.20$58.39+23.7%
1.6%
BMRNBIOMARIN PHARMACEUTICAL INC$52.4M1.47%$100.61$58.99-41.4%
1.5%
ADMAADMA BIOLOGICS INC$46.2M1.30%$3.87$8.95+131.3%
1.3%
MGTXMEIRAGTX HLDGS PLC$45.4M1.27%$6.48$13.92+114.8%
1.3%
TMCITREACE MEDICAL CONCEPTS INC$44.8M1.26%$22.39$4.21-81.2%
1.3%
VERUXXXXVERU INC$41.5M1.17%β€”β€”
1.2%
ALBOALBIREO PHARMA INC$38.0M1.07%β€”β€”
1.1%
COGTCOGENT BIOSCIENCES INC$37.1M1.04%$11.07$38.69+249.5%
1.0%
VRDNVIRIDIAN THERAPEUTICS INC$35.6M1.00%$28.50$19.40-31.9%
1.0%
RAPTRAPT THERAPEUTICS INC$35.6M1.00%β€”β€”
1.0%

AttivitΓ  Trimestre su Trimestre

Q4 2022 vs. Q3 2022

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
HZNPHORIZON THERAPEUTICS PUB L$109.3M
PCVXVAXCYTE INC$56.1M+23.7%
ZYMEZYMEWORKS DEL INC$35.5M
ACRVACRIVON THERAPEUTICS INC$34.6M
SLDBSOLID BIOSCIENCES INC$18.8M
ROIVROIVANT SCIENCES LTD$15.8M
ISRGINTUITIVE SURGICAL INC$10.6M
SCPHSCPHARMACEUTICALS INC$6.8M

Posizioni Chiuse (8)

TickerEmittenteNozionale
GBTGLOBAL BLOOD THERAPEUTICS IN$158.2M
RLMDRELMADA THERAPEUTICS INC$88.2M
TRAVERE THERAPEUTICS INC$46.0M
SGENSEAGEN INC$43.3M
EWEDWARDS LIFESCIENCES CORP$27.3M
ZYMEZYMEWORKS INC$27.1M
APLSAPELLIS PHARMACEUTICALS INC$25.0M
RCUSARCUS BIOSCIENCES INC$17.4M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
SRPTSAREPTA THERAPEUTICS INC$56.2M+156.6%-84.6%
MDGLPUTMADRIGAL PHARMACEUTICALS INC$190.9M+121.1%+85.0%
RCKTROCKET PHARMACEUTICALS INC$13.1M+115.6%
VERUXXXXVERU INC$-3.4M+101.8%
ATXSASTRIA THERAPEUTICS INC$21.0M+70.9%
BMRNBIOMARIN PHARMACEUTICAL INC$23.9M+50.5%-41.4%
AXGNAXOGEN INC$2.5M+46.2%
IMTXIMMATICS N.V$5.4M+39.7%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
NVRONEVRO CORP$-5.8M-80.0%
PRCTPROCEPT BIOROBOTICS CORP$-8.3M-75.5%
DICEDICE THERAPEUTICS INC$-4.8M-57.3%
HLVXHILLEVAX INC$-6.3M-46.9%
ISEEIVERIC BIO INC$-6.0M-43.2%
ALBOALBIREO PHARMA INC$-7.7M-25.5%
SWTXSPRINGWORKS THERAPEUTICS INC$-30.9M-24.6%
CRNXCRINETICS PHARMACEUTICALS IN$-30.6M-24.1%+133.3%
← Torna agli Hedge Fund